проф. др Љубинка Божић

ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis.

Correlation between skin and clinical features in systemic sclerosis By Ljubinka Božić Majstorović , Snježana Popović Pejičić , Irma Ovčina , Verica Ivanović Prodanović , Jelena Mrdja Editor: Siniša Ristić Abstract Introduction. Systemic sclerosis (SS) is a complex autoimmune disease characterized by chronic progressive organic sclerosis. The aim of this paper is to show the correlation of ultrasound (US) parameters with Rodnan skin score (mRSS), as well as the clinical involvement of other org

Clinical significance of coagulation factor gene mutations

The effect of socio-demographic characteristics on the burnout syndrome of nurses in Republic of Srpska during the COVID-19 pandemic

Immunophenotyping and real-time PCR in clinical treatement of RA patients

The importance of renal impairment in systemic sclerosis

Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks

Odgovor na terapiju mikofenolat mofetilom kod pacijentice sa teškim oblikom sistemskog eritemskog lupusa

Prevalencija intrahospitalnih infekcija na hirurškim klinikama Univerzitetskog kliničkog centra Republike Srpske

Interstitial lung disease in antisynthetase syndrome

Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks

Prikaz slučaja: Prikaz slučaja pacijentice sa sistemskim eritemskim lupusom I dijabetes melitusom tip 1’’

Prikaz slučaja: '' Sekundarna hipertrofična osteoartropatija''

Prikaz slučaja: '' Vilonodularni sinovitis zgloba kuka''

Odgovor na terapiju Rituximabom kod pacijenata sa reumatoidnim artritisom

Prikaz slučaja Behcet-ove bolesti komplicirane sa duodenalnim ulkusom i hematemezama

Prikaz slučaja: Stilova bolest odraslih

Correlation of body mass index and bone mineral density in menopausal women with type 2 diabetes

Correlation of Clinical features of systemic lupus erythematosus and osteoporosis

Primjena adalimumaba u liječenju refraktorne forme Stilove bolesti odraslih

Shoud we think about osteoporosis in psoriatic arthritis

PRIKAZ SLUČAJA – MIKROSKOPSKI POLIANGITIS

PRIKAZ SLUČAJA - SARKOIDOZA SA ZAHVATANJEM PARANAZALNIH SINUSA

Имунофенотипизацијска детерминација специфичних клиничких SLE i RA фенотипова

'Експресија NK-CD16+56+ рецепторксих молекула као биомаркера клиничког одговора након третмана SLE i RA пацијената rituximab-om

''Epidemiološke karakteristike sistemskog eritemskog lupusa u Republici Srpskoj''

Prikaz slučaja: '' Sekundarna hipertrofična osteoartropatija''

Prikaz slučaja: Prikaz slučaja pacijentice sa sistemskim eritemskim lupusom I dijabetes melitusom tip 1’’

Prikaz slučaja: '' Vilonodularni sinovitis zgloba kuka''

Odgovor na terapiju Rituximabom kod pacijenata sa reumatoidnim artritisom

Лице и наличје системског еритемског лупуса